Literature DB >> 1694992

Preparation of asialofetuin-labeled liposomes with encapsulated human interferon-gamma and their uptake by isolated rat hepatocytes.

H Ishihara1, T Hara, Y Aramaki, S Tsuchiya, K Hosoi.   

Abstract

The selective delivery of human recombinant interferon (IFN)-gamma to isolated rat hepatocytes was studied with asialofetuin (AF)-labeled liposomes. AF-liposomes containing buffer solution were initially prepared by the detergent removal method, and IFN-gamma was subsequently encapsulated by the freeze-thawing method without loss of activity. Virtually no free [32P]IFN-gamma was internalized into isolated rat hepatocytes, whereas AF-liposomes containing [32P]IFN-gamma were taken up to a significant degree. Liposomal binding to the hepatocytes (estimated at 4 degrees C) was one-fifth of the uptake (estimated at 37 degrees C). Since the uptake was inhibited by the addition of free AF, AF-liposomes may be taken up by the action of galactose-binding protein on the hepatocytic cell surface. The liposome preparation method reported in this paper provides a useful means for the encapsulation of unstable macromolecules into AF-liposomes. AF-liposomes were found effectively to carry IFN-gamma into hepatocytes in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694992     DOI: 10.1023/a:1015833220179

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  23 in total

1.  A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer.

Authors:  K Sriskandan; P Garner; J Watkinson; K W Pettingale; D Brinkley; F M Calman; D E Tee
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Phosphorylation of human immune interferon (IFN-gamma).

Authors:  H F Kung; E Bekesi
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  Specific incorporation of asialofetuin-labeled liposomes into hepatocytes through the action of galactose-binding protein.

Authors:  T Hara; Y Aramaki; S Tsuchiya; K Hosoi; A Okada
Journal:  Biopharm Drug Dispos       Date:  1987 Jul-Aug       Impact factor: 1.627

4.  Evaluation of a new liposome preparation technique, the freeze-thawing method, using L-asparaginase as a model drug.

Authors:  T Ohsawa; H Miura; K Harada
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-07       Impact factor: 1.645

5.  Intracellular human gamma-interferon triggers an antiviral state in transformed murine L cells.

Authors:  J Sancéau; P Sondermeyer; F Béranger; R Falcoff; C Vaquero
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.

Authors:  T W Chang; S McKinney; V Liu; P C Kung; J Vilcek; J Le
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Evidence for a GTP-binding protein involved in interferon-gamma transduction signal.

Authors:  M Gariglio; A Franco; G Cavallo; S Landolfo
Journal:  J Interferon Res       Date:  1988-08

8.  Binding of human recombinant 125I-interferon gamma to receptors on human cells.

Authors:  S J Littman; C R Faltynek; C Baglioni
Journal:  J Biol Chem       Date:  1985-01-25       Impact factor: 5.157

9.  Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism.

Authors:  E Regoeczi; M T Debanne; M C Hatton; A Koj
Journal:  Biochim Biophys Acta       Date:  1978-07-03

10.  Quantitation and characterization of gamma-interferon receptors on human tumor cells.

Authors:  U Ucer; H Bartsch; P Scheurich; D Berkovic; C Ertel; K Pfizenmaier
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

View more
  3 in total

1.  Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes.

Authors:  Sheng-Jun Mao; Shi-Xiang Hou; Ru He; Liang-Ke Zhang; Da-Peng Wei; Yue-Qi Bi; Hui Jin
Journal:  World J Gastroenterol       Date:  2005-05-28       Impact factor: 5.742

Review 2.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

3.  Tat-mediated delivery of heterologous proteins into cells.

Authors:  S Fawell; J Seery; Y Daikh; C Moore; L L Chen; B Pepinsky; J Barsoum
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.